Cartilage Repair via Subchondral Perforation and Thrombin Biomaterial
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for repairing damaged cartilage, such as bone marrow stimulation, often result in poor clot quality and fibrous tissue formation, leading to inadequate healing and potential joint inflammation, as they either cause excessive bleeding or insufficient bleeding at the defect site.
Innovation Solution
A method involving the creation of perforations in subchondral bone to induce bleeding into cartilage defects, followed by the application of a biomaterial like a surgical hemostat containing thrombin and collagen to enhance clot formation and promote cartilage regeneration, without the need for implants or substrates to fill the perforations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If bone marrow stimulation is performed to induce bleeding and clot formation at the cartilage defect site, then initial repair is promoted, but the resulting formed tissue is often fibrous in nature and lacks the durability of normal cartilage
Solution Approach 1:
The patent changes the chemical parameters of the clotting environment by introducing a thrombin-containing composition. This composition modifies the clot formation process to produce a fibrin-rich matrix with enhanced structural integrity and cartilage-like properties, rather than the typical fibrous tissue resulting from standard bone marrow stimulation alone.
Solution Approach 2:
The invention creates a composite repair tissue by combining bone marrow stromal cells, fibrin matrix, and growth factors. This composite structure integrates the regenerative capabilities of stem cells with the structural support of fibrin and the proliferative signals of growth factors, yielding tissue that is both durable and capable of long-term repair.
2Reliability
If extensive bleeding is induced at the defect site to promote clot formation, then clot quality is improved, but joint inflammation and degradation may occur
Solution Approach 1:
The thrombin-containing composition acts as an intermediary substance that mediates the interaction between bone marrow cells and the defect site. It provides a controlled environment for clot formation, enabling sufficient clot quality without requiring excessive bleeding, thereby preventing joint inflammation while maintaining effective repair.
3Object-affected harmful factors
If minimal bleeding is allowed at the defect site, then joint inflammation is reduced, but insufficient migration of blood, bone marrow, cells, and other components from the subchondral bone into the cartilage defect occurs
Solution Approach 1:
The invention changes the chemical parameters of the defect site environment by introducing thrombin and growth factors. This chemical modification creates a potent attractant that actively draws bone marrow cells and other components into the defect site, enabling sufficient cell migration and repair even with minimal bleeding, thus avoiding joint inflammation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach leads to the formation of an enhanced clot that regenerates cartilage similar in structure and integrity to native cartilage, reducing fibrous tissue formation and joint inflammation, and improving long-term repair outcomes.
Implementation Method 1
applying a biomaterial or surgical hemostat to the defect such that the biomaterial, together with the bone fluid, may combine to completely fill, or at least substantially completely fill, the cartilage defect in order to achieve an enhanced clot within the cartilage defect and cartilage regeneration
Data Source
AI summary
In one embodiment, the present invention includes a method for repairing a cartilage defect including: preparing a cartilage defect by removing unwanted or damaged tissue; creating at least one perforation into or through subchondral bone, below and/or adjacent to the cartilage defect to induce the flow of bone fluid; allowing the bone fluid to bleed through the at least one perforation up into the cartilage defect to fill at least a portion of the cartilage defect; and applying a biomaterial into the defect to produce a clot for cartilage regeneration.